Quantitation of Heat-Shock Proteins in Clinical Samples Using Mass Spectrometry

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mass spectrometry (MS) is a powerful analytical tool for proteomics research and drug and biomarker discovery. MS enables identification and quantification of known and unknown compounds by revealing their structural and chemical properties. Proper sample preparation for MS-based analysis is a critical step in the proteomics workflow because the quality and reproducibility of sample extraction and preparation for downstream analysis significantly impact the separation and identification capabilities of mass spectrometers. The highly expressed proteins represent potential biomarkers that could aid in diagnosis, therapy, or drug development. Because the proteome is so complex, there is no one standard method for preparing protein samples for MS analysis. Protocols differ depending on the type of sample, source, experiment, and method of analysis. Molecular chaperones play significant roles in almost all biological functions due to their capacity for detecting intracellular denatured/unfolded proteins, initiating refolding or denaturation of such malfolded protein sequences and more recently for their role in the extracellular milieu as chaperokines. In this chapter, we describe the latest techniques for quantitating the expression of molecular chaperones in human clinical samples.

Cite

CITATION STYLE

APA

Kaur, P., & Asea, A. (2011). Quantitation of Heat-Shock Proteins in Clinical Samples Using Mass Spectrometry. In Methods in Molecular Biology (Vol. 787, pp. 165–188). Humana Press Inc. https://doi.org/10.1007/978-1-61779-295-3_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free